Depressive Disorder
Pipeline by Development Stage
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (11)
Total enrollment: 3,272 patients across 11 trials
A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With Depression
A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder
Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions
Optimizing tDCS Protocol for Clinical Use in Major Depressive Disorder
Efficacy Study of a Computer Decision Support System to Treat Depression
Observational Study to Assess a 6-months Treatment With Gladem